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The seeding and colonization of the thymus by bone marrow stem cells and the maturation of
these cells into mature T lymphocytes are dependent on cell-surface recognition events between
different cell lineages within the thymic microenvironment. Positive and negative selection
processes within the thymus produce a peripheral T-cell repertoire capable of recognizing
peptides derived from foreign antigen bound to self MHC molecules. In addition to the TCR/
MHC-peptide interaction, many other cell-surface molecules act in concert to regulate the
kinetics of cellular interactions and intracellular signaling events during thymopoiesis. We have
investigated the complexity of the thymic stroma by using monoclonal antibodies to clone cell-
membrane molecules of thymic stromal cells. Thymic-shared antigen-1 (TSA-1) is a molecule of
interest because it is expressed by both immature thymocytes and stromal cells. We report herein
the structural and evolutionary relationships between TSA-1 and molecules of the Ly-6
superfamily (Ly-6SF), and present evidence that TSA-1 functions as a cell-surface receptor by
binding a cognate cell target molecule on the surface of a subset of thymocytes.
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INTRODUCTION
Cell-adhesion mechanisms are responsible for deter-
mining the overall tissue architecture within a parti-
cular organ. Plasma membrane molecules are major
regulators of adhesion events in cellular interactions
and they are also responsible for transduction of
external stimuli into the cytoplasm. Cell-adhesion
receptors are usually members of the immuno-
globulin, integrin, and selectin superfamilies, which
can interact with other adhesion receptors on adjacent
cells or with components of the extracellular matrix
(Gumbiner, 1996). Within the thymus, normal cellular
differentiation requires interactions between develop-
ing thymocytes and stromal cells, a complex network
of cell types, including epithelial cells, macrophages,
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and dendritic cells (Boyd et al., 1993). The interaction
between thymic stromal cells and thymocytes is
bidirectional, and the development and function of the
thymic stroma and thymocytes themselves are inter-
dependent (Ritter and Boyd, 1993). Thymic-shared
antigen-1 (TSA-1) was initially defined as a cell-
surface molecule expressed on both immature thymo-
cytes and thymic stromal cells (Godfrey et al., 1992).
TSA-1 is also expressed at most stages of B
lymphopoiesis, thymic dendritic cells, and activated T
cells (Godfrey et al., 1992; Vremec et al., 1992;
Kosugi et al., 1994). Monoclonal antibodies (mAbs)
to TSA-1 have been shown to block an in vitro model
of thymopoiesis, fetal thymus organ culture, or FTOC
(MacNeil et al., 1993; Randle et al., 1993), TcR-
mediated thymocyte apoptosis (Noda et al., 1996),
and mature T-cell responses to antigen (Kosugi et al.,
1994; Saitoh et al., 1995). This suggests a role for
TSA-1 as a cell-surface adhesion molecule in T cells,
with an associated signal-transduction role, possibly
in conjunction with the TcR complex. We have
undertaken cDNA and genomic sequence analysis to
reveal evolutionary relationships between TSA-1 and
other proteins of the Ly-6SF. We have also investi-
gated whether TSA-1 may function as a receptor by
expressing a soluble form of the molecule as a fusion
protein, and using this reagent to identify putative
cell-surface ligands.
RESULTS
Sequence Homology and Genomic Structure
TSA-1 is a cell-surface protein comprising a single
domain of 81 amino acids, which is membrane-
anchored by a C-terminal GPI moiety (MacNeil et al.,
1993; Classon and Coverdale, 1994). TSA-1 is a
member of the Ly-6SF, a family of cell-surface and
soluble proteins defined on the basis of sequence
homology (Gumley et al., 1995a; Palfree et al., 1996).
TSA-1 and several representative Ly-6SF sequences
are shown aligned in Figure 1A. The data highlight
the structural similarities among TSA-1, Ly-6C, and
Ly-6A/E, in particular the conservation of 10 Cys
residues in the single extracellular domain. Also
notable is the Cys-Asn dipetide at or near the C
terminus for all molecules. Also shown in Figure 1A
are the postsynaptic a-cobratoxin and CD59, which
share a similar two- and three-stranded /3-sheet
structure, and are themselves members of the Ly-6SF
(Kieffer et al., 1994). The cobratoxin sequence is
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FIGURE (A) Sequence homology between TSA-1 and the Ly-6SF. The sequence of TSA-1 is shown aligned with four other Ly-6SF
molecules: Ly-6A (LeClair et al., 1986), Ly-6C (Palfree et al., 1988), CD59, and c-cobratoxin. (B) Gene structure of TSA-1. The intron/exon
structure is drawn to scale for TSA-1 (Classon and Coverdale, 1996). The intron and exon sizes (in nucleotides) for single-domain Ly-6SF
molecules whose gene sequences are known are indicated. The gene sequences were obtained from Ly-6A/E (Palfree et al., 1988); Ly-6C
(Bothwell et al., 1988); ThB (Gumley et al., 1995b); Ly-6F and Ly-6G (Fleming et al., 1993); and CD59 (Petranka et al., 1992).TSA-1 AND CELL ADHESION 151
but the three-dimensional structure reveals a similar
protein folding pattern to CD59. In the mouse, most
Ly-6SF genes map to chromosome 15 (LeClair et al.
1987, Kaimura et al., 1992), and in humans, several
Ly-6SF genes have been mapped to chromosome
8q24.3-qter (Brakenhoff et al., 1995; Furuhata et al.,
1996), which is syntenic with mouse chromosome 15.
The genomic organization of TSA-1 (Classon and
Coverdale, 1996) reveals the characteristic intron/
exon structure as seen for other members of the Ly-
6SF (Figure 1B). The exon sizes for the Ly-6SF genes
(Figure 1B) are very similar, suggesting that all Ly-
6SF genes derived from a common ancestral pre-
cursor by gene duplication.
Production of a Soluble TSA-1 Fusion Protein
TSA-1 has a single extracellular protein domain with
a C-terminal GPI anchor. The GPI anchor signal
sequence is characteristically a sequence of hydro-
phobic amino acids at the C terminus of the protein-
coding region, which directs attachment of a GPI
anchor (Ferguson and Williams, 1988). In order to
express a soluble form of TSA-1, we generated a
chimeric cDNA in which the TSA-1 GPI signal
sequence was replaced with a short cDNA segment,
encoding 23 amino acids of the extracellular "hinge"
region of the rat CDS chain, followed by a
translation stop codon (Figure 2A). This segment of
CD8 contains O-linked glycans and facilitates
expression of protein domains that are otherwise not
expressed (Classon et al., 1992). A mouse anti-rat
CD8 mAb (OX8) specific for a sialic-acid-dependent
epitope contained within this 23 amino acid segment
was used (1) to detect fusion proteins and (2) to create
a bivalent complex prior to screening for putative
binding proteins (see what follows). The chimeric
cDNA was ligated into the expression plasmid pEE6
and transfected into CHO-K1 cells. Soluble sTSA-
1/CD8 fusion protein was detected by ELISA (Figure
2B) and was found to react with two different anti-
TSA-1 mAbs, suggesting the material was expressed
in native form. Fusion protein was purified from
CHO-cell supernatant by immunoaffinity chromato-
graphy using an MTS-35 mAb column. The immuno-
purified material eluted from the affinity column was
judged to be a homogeneous monomer by SDS-
PAGE (Figure 2C). Immunopurified sTSA-1 eluted
from the MTS-35 column retained antigenicity, as
determined by ELISA, and migrated as a monomer by
gel filtration (data not shown). Expression levels were
estimated by UV spectroscopy (assuming el%/lcm
10) and silver staining by SDS-PAGE to be approxi-
mately 0.2 mg/1.
Identification of a Putative TSA-1 Cell-Surface
Ligand
The presence of TSA-1 on the cell surface of
immature thymocytes and thymic stromal elements
suggested that either a cell surface or a soluble ligand
exists for TSA-1. To investigate the former poss-
ibility, sTSA-1/CD8 fusion protein was used as a
labeling reagent to identify putative cell-surface
ligand(s). The fusion protein was crosslinked with
biotinylated OX8 mAb (see Materials and Methods)
prior to incubating the complex with target cells.
After washing, the bound fusion protein/mAb com-
plex was detected with a streptavidin-phycoerythrin
conjugate. As shown in Figure 3, approximately 10%
of thymocytes showed weak, but significant staining
over background levels (Figure 3, left panel). The
negative control for the labeling experiment was a
single T-cell receptor Vce8 chain/CD8 fusion protein,
which showed no significant binding. The binding of
sTSA-1 to the cell surface was lower than the levels
seen for a biotinylated anti-CD8/3 mAb, 53.5 (Figure
3, right panel), and the most likely explanation for this
is that sTSA-1 is binding to its target structure with
relatively low affinity. Similar experiments with
lymph-node cells failed to show significant binding of
the sTSA-1 fusion protein. Further experiments to
identify lymphoid and stromal-cell lines capable of
binding the TSA-1/CD8 fusion protein are in pro-
gress.
DISCUSSION
Molecules of the Ly-6SF are differentially expressed
throughout haematopoiesis, suggesting an important152 B.J. CLASSON and R. L. BOYD
role for these molecules in the development and
function of the immune system. Within the thymus,
TSA-1 is expressed throughout T-cell development
until the mature, single-positive cell stage, at which
point expression is downregulated (Godfrey et al.,
1992). TSA-1 is also expressed on thymic stromal
elements, and it is possible that TSA-1 is important in
the organization of epithelial-cell networks and inter-
actions between lymphocytes and stromal cells.
Blockade of FTOC with a TSA-1 mAb arrests T-cell
development just prior to the CD4+CD8 stage.,
suggesting an important function for TSA-1 in
thymopoiesis (MacNeil et al., 1993; Randle et al.,
1993). TSA-1 may be involved in signal transduction
because TSA-1 mAbs block TcR-mediated apoptosis
in thymocytes (Noda et al., 1996) and inhibit IL-2
release by activated T cells (Saitoh et al., 1995). The
results presented herein show that sTSA-1 fusion
protein binds to a subset of thymocytes, consistent
with the presence of a TSA-1 ligand on these cells. It
is possible that the interaction between TSA-1 and its
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FIGURE 2 Expression of TSA-1/CD8 fusion protein. (A) The TSA-I cDNA corresponding to the extracellular domain (Classon and
Coverdale, 1994) was assembled and expressed in CHO cells as a CD8 fusion protein. (B) ELISA of sTSA-1/CD8 fusion protein with two
different TSA-1 mAbs, MTS-35 and E3 81-2.4, as solid-phase capture reagents. (C) SDS-PAGE of immunopurified sTSA-1/CD8 fusion
protein. Molecular weight markers (in kilodaltons) are indicated.TSA-1 AND CELL ADHESION 153
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FIGURE 3 A putative cell-surface ligand for TSA-1 expressed on a subpopulation of thymocytes. Thymocytes were labeled with a
preformed complex of sTSA-1 and OX8-biotin (see Materials and Methods), and the bound complex was detected with phycoerythrin-
conjugated streptavidin.
FTOC, giving rise to blockade of development prior
to the CD4+CD8 stage. An alternative explanation is
that the TSA-1 mAb cross-links TSA-1 at the cell
surface and delivers a negative signal to the develop-
ing T cell. This negative signal may reflect normal
TSA-1 function, or it may be an artifactual signal due
to receptor cross-linking with a multivalent, high-
affinity mAb ligand. Attempts to inhibit FTOC with
anti-TSA-1 Fab fragments and soluble TSA-1 fusion
protein are currently underway. These reagents are
monovalent and would not be expected to trigger an
aberrant response by cross-linking surface receptors
nor induce antigen loss by capping.
Another Ly-6SF molecule, Ly-6A/E, is also
expressed on early thymocytes and thymic stromal
cells, but unlike TSA-1, it is also expressed on
multipotential bone marrow stem cells (hence its
alternative name, stem-cell antigen-l, Sca-1). Ly-6A/
E is expressed on early thymocyte precursors, down-
regulated as thymocytes develop into the CD4+CD8
stage, and then reexpressed on mature thymocytes
(Yeh et al., 1986; Spangrude et al., 1988). Pan-thymic
overexpression of Ly-6A/E as a transgene with a CD2
promoter results in a block of T-cell differentiation at
the CD4+CD8 stage, where Ly-6A/E expression is
normally downregulated (Bamezai et al., 1995). This
result shows the importance of precise regulation of
Ly-6A/E expression during thymopoiesis, and over-
expressing Ly-6A/E may deliver a dominant negative
signal to the thymocyte, possibly related to the mAb
induced in vitro blockade ofFTOC with TSA-1 mAbs
(Randle et al., 1993). Ly-6A/E mAbs have been
shown to block IL-2 release by activated T cells, in
similar fashion to TSA-1 mAbs (Codias et al., 1990;
Izon et al., 1996). Given their sequence homology, it
is possible that Ly-6A/E has a similar function to
TSA-1, despite their different patterns of tissue
expression.
Ly-6SF molecules were initially defined as
differentiation antigens of lymphocytes. It is now
clear that Ly-6SF molecules are not restricted to
lymphoid tissues. Ly-6A/E, for example, is expressed
at high levels on tubular epithelium and vascular
endothelium in the kidney (Blake et al., 1993), and in
vasculature of the heart, brain, and liver (van de Rijn
et al., 1989). TSA-1 is also expressed in kidney and
liver (Classon and Coverdale, 1996). In mice, ThB is
expressed in thymocytes and B cells (Gumley et al.,154 B.J. CLASSON and R. L. BOYD
1995b), whereas in humans, ThB is apparently not
expressed in lymphocytes, but is found as a com-
ponent of desmosomes, where it is known as desmo-
glein III/dg 4 (Quak et al., 1990; Schrijvers et al.,
1991; Brakenhoff et al., 1995). Desmosomes are
intercellular organelles found at cell junctions and
that mediate adhesion between epithelial cells in
many tissues. ThB is localized to the midline of
desmosomes, suggesting a structural role in desmo-
some formation and intercellular adhesion (Quak et
al., 1990). Given the structural similarities and similar
tissue distribution of ThB and TSA-1, it will be of
interest to investigate whether TSA-1 or any other Ly-
6SF molecules are also expressed in desmosomes.
Structural similarities suggested by sequence
homology points to related functions for Ly-6SF
molecules. Four members of the family have well-
defined function, namely, the postsynaptic neuro-
toxins, the urokinase plasminogen activator (uPA)
receptor, the phospholipase A2 inhibitor, and CD59.
Each of these proteins has evolved to bind target
structures, although the nature of the target molecules
vary significantly. The neurotoxins of snake venoms
are well-characterized inhibitors of neuromuscular
transmission that act by binding nicotinic acetylcho-
line receptors (Endo and Tamiya, 1987). uPAR
provides the cell with proteolytic potential for degra-
dation of the extracellular matrix important for cell
migration, and is also capable of interacting with and
modifying the function of activated integrin mole-
cules (Grondahl-Hansen et al., 1988; Stefansson and
Lawrence, 1996; Wei et al., 1996). A phospholipase
A2 inhibitor found in snake plasma affords host
protection from phospholipase A2, a major degra-
dative enzyme component of many venoms (Fortes-
Dias et al., 1994). CD59 protects host cells from
autologous lysis by inhibiting formation of the
terminal membrane attack complex of complement
(Davies and Lachmann, 1993).
Several studies have shown a possible role for Ly-
6SF molecules in lymphocyte-cell adhesion. Evidence
reported herein suggests that TSA-1 is a cell-surface
receptor capable of interacting with a target ligand on
the surface of thymocytes. Cell-aggregation assays
have shown that Ly-6A/E also binds a heterologous
ligand on the surface of lymphoid cells (Bamezai and
Rock, 1995), Ly-6C may also function as an adhesion
molecule in CTL-target cell interactions (Johnson et
al., 1993), and ThB has been shown to be involved in
cell-adhesion phenomena (Schrijvers et al., 1991). At
present, the molecular nature of these ligands is
unclear, and it is conceivable that several molecules
share the same ligand. Further experiments involving
gene-deficient mice and soluble fusion proteins will
clarify the role of the Ly-6SF molecules, and their
putative ligands, in tissue organization and adhesion




The sequences shown in Figure 1 were aligned using the
Multiple Sequence Alignment program at Washington
University (http://www.ibc.wustl.edu/msa.html).
Soluble Fusion Protein and ELISA
A chimeric cDNA comprising the extracellular
domain of TSA-1 and the N-terminal leader sequence
(codons -26 to +81; Classon and Coverdale, 1994)
joined to the rat CD8 hinge sequence was made
according to previously published methods (Classon
et al., 1992), except that only the first 23 amino acids
of the 46 amino acid rat CD8 hinge sequence was
used. Fusion protein expressed in CHO-cell super-
natant was quantitated by ELISA. Briefly, PVC plates
were coated with 25 /xg/ml of either TSA-l-specific
mAb (MTS-35 or E3 81-2.4). After blocking with
BSA, plates were incubated with titrated amounts of
tissue-culture supernatant, washed, and then reacted
with biotinylated OX8 mAb, which recognizes the C
terminus of the TSA-1 fusion protein. After washing,
the wells were then incubated with an appropriate
dilution of streptavidin-HRPO conjugate (Dako) and
then developed with 2,2’-azino-bis(3-ethylbenzthia-
zoline-6-sulphonic acid, diammonium salt (ABTS;
Sigma) and read in an ELISA plate reader (Titre-
tek).TSA-1 AND CELL ADHESION 155
Cell-Surface Labeling and FACS Analysis
Single-cell suspensions of thymocytes and lymph-
node cells were prepared and labeled with a pre-
formed complex of sTSA-1/CD8 fusion protein and
biotinylated OX8 mAb. The fusion protein:mAb ratio
was determined by inhibition ELISA. Briefly, titrated
amounts of sTSA-1/CD8 fusion protein were mixed
with a fixed amount of OX8-biotin, such that a 50%
inhibition of OX8-biotin binding to immobilized
sTSA-1/CD8 was achieved. A second fusion protein,
containing a single TcR Vce8 domain fused to the
CD8 hinge sequence, was used as a negative staining
control at the same concentration as the sTSA-1
fusion protein. In each case, bound fusion protein was
detected using phycoerythrin-conjugated streptavidin
(Caltag) and cells were analyzed using a FACScan
(Becton Dickinson).
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